Preprocedural Planning of Left Atrial Appendage Occlusion: A Review of the Use of Additive Manufacturing.
Sara ValvezManuel Oliveira-SantosLino GonçalvesAna M AmaroAna P PiedadePublished in: 3D printing and additive manufacturing (2024)
Stroke is a significant public health problem, with non-valvular atrial fibrillation (NVAF) being one of its main causes. This cardiovascular arrhythmia predisposes to the production of intracardiac thrombi, mostly formed in the left atrial appendage (LAA). When there are contraindications to treatment with oral anticoagulants, another therapeutic option to reduce the possibility of thrombus formation in the LAA is the implantation of an occlusion device by cardiac catheterization. The effectiveness of LAA occlusion is dependent on accurate preprocedural device sizing and proper device positioning at the LAA ostium, to ensure sufficient device anchoring and avoid peri-device leaks. Additive manufacturing, commonly known as three-dimensional printing (3DP), of LAA models is beginning to emerge in the scientific literature to address these challenges through procedural simulation. This review aims at clarifying the impact of 3DP on preprocedural planning of LAA occlusion, specifically in the training of cardiac surgeons and in the assessment of the perfect adjustment between the LAA and the biomedical implant.
Keyphrases
- atrial fibrillation
- left atrial appendage
- oral anticoagulants
- catheter ablation
- left atrial
- public health
- direct oral anticoagulants
- heart failure
- systematic review
- percutaneous coronary intervention
- randomized controlled trial
- coronary artery disease
- high resolution
- virtual reality
- quality improvement
- acute coronary syndrome
- soft tissue
- cerebral ischemia
- venous thromboembolism
- subarachnoid hemorrhage
- combination therapy
- thoracic surgery